Dendreon is a leading company in Seal Beach, CA, revolutionizing medicine through their expertise in cellular technology. With a focus on improving the lives of patients, they develop innovative science and cellular therapies, enabling the future of complex cell therapies through research, development, and strategic partnerships.
As pioneers in the field, Dendreon's flagship innovation, PROVENGE sipuleucel-T, was the first FDA-approved cellular immunotherapy available in the market. With their extensive experience, knowledge, and logistics, they also assist other companies in bringing life-saving innovations to market, from clinical research to manufacturing, making them a key player in the development of game-changing cellular therapies.
Generated from the website